PVM
BMY icon

Palogic Value Management’s Bristol-Myers Squibb BMY Stock Holding History

Palogic Value Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-33,415
Closed -$1.55M – 170
2025
Q2 		$1.55M Buy
33,415
+125
+0.4% +$6.14K 0.63% 45
2025
Q1 		$2.03M Buy
33,290
+1,508
+5% +$87.9K 0.88% 38
2024
Q4 		$1.8M Buy
31,782
+128
+0.4% +$7.15K 0.68% 47
2024
Q3 		$1.64M Buy
31,654
+453
+1% +$21.3K 0.56% 51
2024
Q2 		$1.3M Buy
31,201
+284
+0.9% +$12.7K 0.55% 60
2024
Q1 		$1.68M Buy
30,917
+573
+2% +$29.2K 0.73% 50
2023
Q4 		$1.56M Buy
30,344
+706
+2% +$37.1K 0.69% 50
2023
Q3 		$1.72M Buy
29,638
+210
+0.7% +$12.9K 0.82% 44
2023
Q2 		$1.88M Buy
29,428
+61
+0.2% +$4.09K 0.88% 42
2023
Q1 		$2.04M Buy
29,367
+515
+2% +$36.3K 1% 31
2022
Q4 		$2.08M Buy
+28,852
New +$2.18M 1.08% 25

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Palogic Value Management's BMY Position: Q3 2025 in Review

Palogic Value Management sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 33,415 shares — an estimated $1.55M sold.

Palogic Value Management first reported a position in BMY in Q4 2022 and held it in 11 quarters. The position peaked at $2.08M in Q4 2022. 2,268 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Palogic Value Management reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • Palogic Value Management sold 33,415 Bristol-Myers Squibb shares in Q3 2025, an estimated $1.55M.
  • Palogic Value Management first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 11 quarters.
  • Palogic Value Management's Bristol-Myers Squibb position peaked at $2.08M in Q4 2022.
  • 2,268 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Palogic Value Management's 13F filing for Q3 2025, filed 14 Nov 2025.